BioPorto A/S (CPH:BIOPOR)
Denmark · Delayed Price · Currency is DKK 1.140
-0.030 (-2.56%)
May 6, 2026, 4:59 PM CET
BioPorto Earnings Call Transcripts
Fiscal Year 2025
-
AKI and CKD are rising globally, with new diagnostics and treatments improving outcomes but access and workforce shortages remain major challenges. AI and biomarkers are transforming early detection, while care coordination and patient advocacy are essential for better kidney health.
Fiscal Year 2024
-
A global commercial platform for early AKI detection is being built, focusing first on pediatric ICUs and expanding to adults and international markets. Sales momentum is strong, with key partnerships and clinician engagement driving adoption, and regulatory and reimbursement strategies are actively managed.